• Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Careers
  • Tools
Finnegan
  • News
  • Finnegan Facts
  • History
  • Diversity
  • Pro Bono
  • Offices
  • Management

Press Release

Finnegan Celebrates Two Wins at the 2020 LMG Life Sciences Awards and Top Honors in the Rankings

October 5, 2020

FOR IMMEDIATE RELEASE
October 5, 2020

WASHINGTON, DC—At the 2020 LMG Life Sciences Awards virtual ceremony, Finnegan received the awards for “Patent Strategy Firm of the Year” and “Patent Impact Case of the Year.”

The “Patent Impact Case of the Year” award reflects the firm’s appellate victory in Kaken Pharmaceutical Co., Ltd.; Bausch Health Care v. Andrei Iancu. At the U.S. Court of Appeals for the Federal Circuit, on behalf of clients Kaken Pharmaceuticals and Bausch Health, Finnegan obtained a decision reviving a key patent covering the Jublia® pharmaceutical product directed to methods of using efinaconazole to treat onychomycosis. In the case on appeal from an inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB), Finnegan argued that the final written decision finding the patent obvious and therefore unpatentable was based on an erroneous claim construction ruling. The Federal Circuit agreed and issued a precedential opinion overturning the PTAB’s claim construction of a key term in the patent, reversing the PTAB’s finding of obviousness that led to the finding of unpatentability, and remanding the case back to the Board. The patent at issue, which is being asserted in multiple concurrent district court litigations, provides patent protection for Jublia® until 2026. Jublia® has achieved more than $1B in sales since launch.

LMG’s Patent Strategy Firm of the Year award recognizes Finnegan’s strength in working with innovators dedicated to creating life-saving and life-improving products, proving first-hand how deliberate and holistic IP asset protection makes the difference, particularly when it comes to enforcing rights to keep competitors at bay or defending against infringement allegations.

In addition to receiving two awards, the firm once again received top honors in the LMG Life Sciences rankings. Finnegan ranked as “highly recommended” in the intellectual property categories of Patent Prosecution, Patent Strategy & Management, General Patent Litigation, and Hatch-Waxman Patent Litigation (Branded). Finnegan’s Life Sciences practice includes more than 250 attorneys and professionals dedicated to serving our clients’ intellectual property needs in the biologics, biotechnology, branded Hatch-Waxman (ANDA), digital health, medical device and diagnostics, and pharmaceutical spaces. The following attorneys were ranked as 2020 LMG Life Sciences Stars:

Michele C. Bosch - General Patent Litigation, Patent Strategy & Management

Scott Burwell - General Patent Litigation, Hatch-Waxman Patent Litigation

Bryan C. Diner - Hatch-Waxman Patent Litigation, Patent Strategy & Management

Thomas L. Irving - Patent Prosecution, Patent Strategy & Management, General Patent Litigation

Michael Jakes - General Patent Litigation, Patent Strategy and Management

Howard W. Levine - General Patent Litigation, Hatch-Waxman Patent Litigation, Patent Strategy & Management

Charles E. Lipsey - General Patent Litigation, Hatch-Waxman Patent Litigation

John D. Livingstone - Hatch-Waxman Patent Litigation

Jill K. MacAlpine, Ph.D. - General Patent Litigation, Patent Strategy & Management, Hatch-Waxman Patent Litigation, Patent Prosecution

Leslie A. McDonell - Patent Prosecution, Patent Strategy & Management, General Patent Litigation

James B. Monroe - General Patent Litigation

William B. Raich, Ph.D. - General Patent Litigation

Barbara R. Rudolph Ph.D. - General Patent Litigation, Hatch-Waxman Patent Litigation

 

Contacts
Anand K. Sharma, Managing Partner 
anand.sharma@finnegan.com 

Mark D. Sweet, Chair 
mark.sweet@finnegan.com 


About Finnegan
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is one of the largest IP law firms in the world. From offices in Atlanta, Boston, London, Palo Alto, Reston, Seoul, Shanghai, Taipei, Tokyo, and Washington, DC, the firm practices all aspects of patent, trademark, and copyright, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to advertising, trade secret law, European patents and trade marks, international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com. Follow us on LinkedIn and Twitter.

Tags

LMG Life Sciences

Related Practices

Patent Litigation

Branded Hatch-Waxman (ANDA)

Patent Office Examinations

Prosecution

Related Industries

Life Sciences

Pharmaceutical

Medical Device and Diagnostics

Digital Health

Biotechnology

Biologics

Related Professionals

Michele_Bosch
Michele C. Bosch
Partner
Washington, D.C.
+1 202 408 4193
Email
L_Scott_Burwell
L. Scott Burwell
Partner
Reston, VA
+1 571 203 2721
Email
Bryan_Diner
Bryan C. Diner
Partner
Washington, D.C.
+1 202 408 4116
Email
Thomas_Irving
Thomas L. Irving
Partner
Washington, D.C.
+1 202 408 4082
Email
J_Michael_Jakes
J. Michael Jakes
Partner
Washington, D.C.
+1 202 408 4045
Email
Charles_Lipsey
Charles E. Lipsey
Partner
Reston, VA
+1 571 203 2755
Email
John_Livingstone
John D. Livingstone
Partner
Atlanta, GA
+1 404 653 6449
Email
Jill_MacAlpine
Jill K. MacAlpine, Ph.D.
Partner
Washington, D.C.
+1 202 408 4105
Email
Leslie_McDonell
Leslie A. McDonell
Partner
Boston, MA
+1 617 646 1650
Email
James_Monroe
James B. Monroe
Partner
Washington, D.C.
+1 202 408 4159
Email
William_Raich
William B. Raich, Ph.D.
Partner
Washington, D.C.
+1 202 408 4210
Email
Barbara_Rudolph
Barbara R. Rudolph, Ph.D.
Partner
Washington, D.C.
+1 202 408 4346
Email

Related News

Media Mention

PTAB 2020 Rankings: Top Petitioners, Patentees and Law Firms

January 11, 2021

Press Release

Finnegan Elevates Six Attorneys to Partner

January 4, 2021

Announcement

Finnegan Announces 2020 Mentors of the Year

December 28, 2020

What Mattered in 2020? Industry Experts Have Their Say on This Year's Biggest Moments in IP

December 27, 2020

Commentary

5 Big Developments that Shaped the PTAB in 2020

December 18, 2020

Commentary

How I Made Partner: Finnegan's Danielle Duszczyszyn Shares Six Keys to Business Development Success

December 16, 2020

Press Release

Finnegan Accepting Applications for 2021 Diversity Scholarship

November 30, 2020

Press Release

Seven Finnegan Partners Named IAM Global Leaders

November 25, 2020

Press Release

Finnegan Remains at Tier 1 in 2021 U.S. News & World Report and Best Lawyers Rankings

November 16, 2020

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

  • Privacy
  • Disclaimer
  • EEO Statement

© 2021 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP